Atlas Trials

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Clinical trial NCT05419492 · RECRUITING

Trial details

NCT number
NCT05419492
Sponsor
Encoded Therapeutics
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dravet Syndrome
Start date
2024-05-14
Primary completion
2028-01-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.